- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
June 5th, 2007
Im's research could have applications in nanotechnology and pharmaceuticals.
"The aim of our work is to understand human disease at the molecular level," said Im. "If you look at the drugs that we're using now, about 50 percent of commercial drugs are targeting membrane proteins. As our research progresses, we hope to help make a map to develop the drugs of the future."
A committee of researchers reviews more than 500 nominations each year to determine a final selection of 116 Sloan fellows in seven scientific fields.
|Related News Press|
Stealth nanocapsules kill Chagas parasites in mouse models June 22nd, 2016
Yale researchersí technology turns wasted heat into power June 27th, 2016
FEI Launches Helios G4 DualBeam Series for Materials Science: The Helios G4 DualBeam Series features new capabilities to enable scientists and engineers to answer the most demanding and challenging scientific questions June 27th, 2016